|
Journal
Papers, Abstracts, and Commentaries
| |
Relationship between retinal nerve fiber
layer thickness and driving ability in patients with humanimmunodeficiency virus infection. Cheng S, Klein H, Bartsch DU,
et al
Graefes Arch Clin Exp Ophthalmol.
2011 Jul 6
Abstract
Diffuse infiltrative syphilitic retinitis in an
HIV-positive patient.
Rahman HT, Yeh S.J
Ophthalmic Inflamm Infect.
2011 Jun 26..
Abstract
Fluocinolone acetonide implant (retisert) for
chronic cystoid macular edema in two patients with AIDS
and a history of cytomegalovirus retinitis.
Hu J, Coassin M, Stewart JM.
Ocul Immunol Inflamm. 2011
Jun;19(3):206-9.
Abstract
Challenging cases discussed by experts:
retinal vasculitis following coinfection with HIV and
syphilis.
Albini T, Davis JL, Tuda CD.
J Ophthalmic Inflamm Infect.
2011 Apr 22.
Abstract
Proliferative Vitreoretinopathy in Human
Immunodeficiency Virus-Infected Patients
in the Era of Highly Active Antiretroviral Therapy. Kunavisarut P, Bijlsma WR, Pathanapitoon K, et al
Am J Ophthalmol.
2010 Jun 3.
Abstract |
Retinal Findings in Chinese Patients with HIV
Infection.
Wang J, You Q, Yang H, et al
Ophthalmic Res. 2008 Jan
25;40(2):98-100
Abstract
|
Extensive retinal neovascularization as a late
finding in human
immunodeficiency virus-infected patients with immune recovery uveitis.
Wright ME, Suzman DL, Csaky KG
Clin Infect Dis 2003 Apr
15;36(8):1063-6
Abstract
Retinal microangiopathy in human immunodeficiency virus infection is
related to
higher human immunodeficiency virus-1 load in plasma.
Furrer H, Barloggio A, Egger M, Garweg JG.
Ophthalmology 2003 Feb;110(2):432-6
Abstract |
|
Journal Papers,
Abstracts, and Commentaries
| |
Risk of vision loss in patients with cytomegalovirus retinitis and
the acquired
immunodeficiency syndrome.
Kempen JH, Jabs DA, Wilson LA, et al.
Arch Ophthalmol 2003
Apr;121(4):466-76
Abstract
Retinal detachment in cytomegalovirus
retinitis: intravenous versus intravitreal therapy.
Young S, McCluskey P, Minassian DC, et al
Clin Experiment Ophthalmol
2003 Apr;31(2):96-102
Abstract
Quantitation of cytomegalovirus (CMV) DNA by
real-time PCR for occurrence of CMV
disease in HIV-infected patients receiving highly active
antiretroviral therapy.
Gourlain K, Salmon D, Gault E, et al.
J Med Virol 2003 Mar;69(3):401-7
Abstract
Pharmacokinetics and renal effects of
cidofovir with a reduced dose of probenecid in
HIV-infected patients with cytomegalovirus retinitis.
Wolf DL, Rodriguez CA, Mucci M, et al.
J Clin Pharmacol 2003 Jan;43(1):43-51
Abstract
Cytomegalovirus Retinitis after Initiation of Highly Active
Antiretroviral Therapyin
HIV-Infected
Patients: Natural History and Clinical Predictors.
Lin DY, Warren JF, Lazzeroni LC, et al.
Retina 2002
Jun;22(3):268-277
Abstract
Emergence of multiple drug-resistant human cytomegalovirus variants
in 2 patients with
human immunodeficiency virus infection unresponsive to highly active
antiretroviral
therapy.
Baldanti F,Paolucci S, Parisi A
Clin Infect Dis 2002 Apr 15;34(8):1146-9
Abstract
Discontinuation of secondary prophylaxis in patients with
cytomegalovirus retinitis who
have responded to highly
active antiretroviral therapy.
Berenguer J, Gonzalez J, Pulido F , et al.
Clin Infect Dis 2002 Feb
1;34(3):394-7
Abstract
Declining Levels of Rescued
Lymphoproliferative Response to Human Cytomegalovirus
(HCMV) in AIDS
Patients With or Without HCMV Disease
Following Long-Term HAART.
Gerna G, Piccinini G, Genini E, et al
J Acquir Immune Defic Syndr 2001
Dec1;28(4):320-331
Abstract
Characteristics of patients with cytomegalovirus retinitis in the
era of highly active
antiretroviral therapy.
Jabs DA, Van Natta ML, Kempen JH, et al
Am J Ophthalmol 2002 Jan;133(1):48-61
Abstract
Highly active antiretroviral therapy-associated regression of
cytomegalovirus retinitis
long-term results in a small case series.
Reed JB, Briggs JW, McDonald JC,
Retina 2001;21(4):339-43
Abstract
|
|
|
Journal Papers,
Abstracts, and Commentaries
|